ENHERTU Type II variation application validated in the EU for previously treated patients with HER2...

The clinical trial approval for SIM0609 (CDH17 Antibody-Drug Conjugate) issued by the National Medical Products...

Chime Biologics and Arbele announce strategic collaboration at BIOHK 2025 signing ceremony

LigaChem Biosciences enters license agreement with GO Therapeutics

Daiichi Sankyo breaks ground on $151M cancer drug plant in Shanghai

Ridge Biotechnologies emerges from stealth with $25 million in seed financing for AI-Enabled precision enzyme and...